Jacobi Capital Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Jacobi Capital Management’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5	Closed	–	–	1384
2021 Q3	$0	Hold	5	–	–	﹤0.01%	1507
2021 Q2	$0	Hold	5	–	–	﹤0.01%	1446
2021 Q1	$0	Hold	5	–	–	﹤0.01%	1470
2020 Q4	$0	Hold	5	–	–	﹤0.01%	1386
2020 Q3	$0	Hold	5	–	–	﹤0.01%	1320
2020 Q2	$0	Hold	5	–	–	﹤0.01%	1285
2020 Q1	$0	Sell	5 -1	-17%	-$14	﹤0.01%	1218
2019 Q4	$0	Hold	6	–	–	﹤0.01%	1108
2019 Q3	$0	Hold	6	–	–	﹤0.01%	1085
2019 Q2	$0	Hold	6	–	–	﹤0.01%	1073
2019 Q1	$0	Buy	+6	New	+$89	﹤0.01%	1036

Other funds holding LUMO

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Jacobi Capital Management's LUMO Position: Q4 2021 in Review

Jacobi Capital Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2021, closing a stake of 5 shares.

Jacobi Capital Management first reported a position in LUMO in Q1 2019 and held it in 11 quarters. The position peaked at $0 in Q3 2021. 38 funds tracked by Wall St. Rank hold LUMO as of Q4 2021.

Jacobi Capital Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Jacobi Capital Management sold 5 Lumos Pharma, Inc. Common Stock shares in Q4 2021.
Jacobi Capital Management first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2019 and held it in 11 quarters.
Jacobi Capital Management's Lumos Pharma, Inc. Common Stock position peaked at $0 in Q3 2021.
38 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2021.

Based on Jacobi Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.